Age-associated Increase in Interleukin 6 in MRL/lpr Mice
Overview
Affiliations
It has been demonstrated that abnormal expression of interleukin 6 (IL-6) may be involved in the pathogenesis of a variety of autoimmune diseases and glomerulonephritis. In this study, we demonstrate an age-associated increase in IL-6 in the sera of MRL/lpr mice but not in control congenic MRL/+ mice, normal strains of BALB/c, C3H/HeN mice, and other autoimmune prone mice, such as (NZB x NZW)F1, (NZB x BXSB)F1 mice. IL-6 activity was detected in the sera of MRL/lpr mice by 3 weeks of age and it was neutralized by anti-mouse IL-6 antibody. The serum IL-6 level was gradually increased with age and reached up to 410 pg/ml around 30 weeks of age. The expression of IL-6 mRNA was detected in the spleen and lymph nodes from 8 weeks of age. Expression of IL-6 mRNA was also detected in C57BL/6-lpr mice, indicating the possible linkage of abnormal expression of the IL-6 gene and the lpr gene. Southern blot analysis demonstrated that both the promoter region and 3' untranslated region of the IL-6 gene were apparently normal, suggesting that deregulated production of IL-6 may be due to abnormal transcriptional control. The data suggest that abnormal expression of the IL-6 gene may play a key role in the development of polyclonal B cell activation and glomerulonephritis in MRL/lpr mice.
Reynolds J, Torz L, Cummins L, Stock A, Ben-Zvi A, Putterman C Fluids Barriers CNS. 2025; 22(1):15.
PMID: 39934822 PMC: 11816793. DOI: 10.1186/s12987-025-00628-x.
The MRL Model: A Valuable Tool in Studies of Autoimmunity-Brain Interactions.
Sakic B Methods Mol Biol. 2024; 2868:221-246.
PMID: 39546233 DOI: 10.1007/978-1-0716-4200-9_12.
Reynolds J, Huang M, Li Y, Meineck M, Moeckel T, Weinmann-Menke J J Neuroinflammation. 2024; 21(1):89.
PMID: 38600510 PMC: 11007930. DOI: 10.1186/s12974-024-03085-9.
OBrien J, Willis A, Long A, Kwon J, Lee G, Li F JCI Insight. 2024; 9(3).
PMID: 38175727 PMC: 11143963. DOI: 10.1172/jci.insight.173246.
Huang X, Yan P, Song X, Zhang S, Deng Y, Huang C Arch Rheumatol. 2023; 37(4):504-516.
PMID: 36879572 PMC: 9985378. DOI: 10.46497/ArchRheumatol.2022.9168.